scispace - formally typeset
S

Soma Das

Researcher at University of Chicago

Publications -  162
Citations -  29990

Soma Das is an academic researcher from University of Chicago. The author has contributed to research in topics: Gene & Exome sequencing. The author has an hindex of 55, co-authored 160 publications receiving 22523 citations. Previous affiliations of Soma Das include University of Illinois at Chicago & NorthShore University HealthSystem.

Papers
More filters
Journal ArticleDOI

Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach.

TL;DR: A targeted next-generation sequencing assay for the detection of mutations in 36 genes known to cause monogenic forms of diabetes, including transient or permanent neonatal diabetes mellitus (TNDM or PNDM), maturity-onset diabetes of the young (MODY) and rare syndromic forms ofabetes.
Journal ArticleDOI

Exome Sequencing and the Genetics of Intellectual Disability

TL;DR: Topper S, Ober C, Das S. Exome sequencing and the genetics of intellectual disability: Causes and treatments.
Journal ArticleDOI

Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer

TL;DR: KDR genetic variation in 3 populations is defined and common variants that impact on tumoral KDR expression and vascularization are identified and may have important implications for understanding the molecular basis of genetic associations between KDR variation and clinical phenotypes related to VEGFR-2 function.
Journal ArticleDOI

Genetic variants contributing to daunorubicin-induced cytotoxicity

TL;DR: A genome-wide model using International HapMap cell lines that integrate genotype and gene expression to identify genetic variants that contribute to daunorubicin-induced cytotoxicity is presented and can be used to elucidate genetic variants contributing to a wide range of cellular phenotypes.
Journal ArticleDOI

Characterization of mutations in fifty North American patients with X-linked myotubular myopathy.

TL;DR: In this paper, mutations detected in 50 additional U.S. families with biopsy-proven X-linked myotubular myopathy (MTM1) were identified.